SCHEMBL4757325

SCHEMBL4757325

Cc1cc(Br)c(C(=O)Nc2nc(S(C)(=O)=O)cs2)cc1Br

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SORT1 Q99523 1/20 0.43
NPC1 O15118 8/20 0.43
RAB9A P51151 8/20 0.43
ALDH1A1 P00352 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
GAA P10253 2/20 0.43
HPGD P15428 3/20 0.41
CASP3 P42574 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41
RECQL P46063 1/20 0.41
KDM4E B2RXH2 2/20 0.39
HTT P42858 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
PDE5A O76074 1/20 0.39
PDE1A P54750 1/20 0.39
PDE1B Q01064 1/20 0.39
PDE1C Q14123 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4757250 0.88 NPC1 (0.41) SORT1NPC1RAB9AALDH1A1MEN1
SCHEMBL4757093 0.84 SORT1 (0.47) SORT1NPC1RAB9AALDH1A1MEN1
SCHEMBL4757362 0.84 SORT1 (0.47) SORT1NPC1RAB9AALDH1A1MEN1
SCHEMBL10114711 0.83 GCK (0.38) SORT1NPC1RAB9AALDH1A1MEN1
SCHEMBL4757021 0.81 SORT1 (0.46) SORT1NPC1RAB9AALDH1A1MEN1
SCHEMBL10114666 0.80 MAPK1 (0.45) SORT1NPC1RAB9AALDH1A1MEN1
SCHEMBL4757072 0.80 PDE5A (0.62) SORT1NPC1RAB9AALDH1A1MEN1
SCHEMBL4756728 0.80 MEN1 (0.47) SORT1NPC1RAB9AALDH1A1MEN1
SCHEMBL4757332 0.79 GCK (0.44) SORT1NPC1RAB9AALDH1A1MEN1
SCHEMBL4757291 0.79 NPC1 (0.49) SORT1NPC1RAB9AALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC SORT1 4431/4885NPC1 585/4885RAB9A 1694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.